Luke Nathaniel Walker - Jan 24, 2023 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role
Chief Medical Officer
Signature
/s/ Frank Lanza, Attorney-in-Fact
Stock symbol
HARP
Transactions as of
Jan 24, 2023
Transactions value $
$0
Form type
4
Date filed
1/26/2023, 03:05 PM
Previous filing
Oct 4, 2022
Next filing
Nov 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Employee Stock Option (right to buy) Award $0 +100K $0.00 100K Jan 24, 2023 Common Stock 100K $0.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total stock option will vest and become exercisable every six months following the vesting commencement date of January 24, 2023, subject to the continuing employment of the Reporting Person on each vesting date.